These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34973218)

  • 1. ICGC-ARGO precision medicine: familial matters in pancreatic cancer.
    Milella M; Luchini C; Lawlor RT; Johns AL; Casolino R; Yoshino T; Biankin AV;
    Lancet Oncol; 2022 Jan; 23(1):25-26. PubMed ID: 34973218
    [No Abstract]   [Full Text] [Related]  

  • 2. ICGC-ARGO precision medicine: an update on familial matters in pancreatic cancer.
    Milella M; Lawlor RT; Luchini C; Johns AL; ; Casolino R; Yoshino T; Biankin AV; Scarpa A
    Lancet Oncol; 2022 Aug; 23(8):991-992. PubMed ID: 35901820
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular landscape of pancreatic cancer: challenges and clinical implications.
    Kyrochristos ID; Ziogas DE; Glantzounis GK; Roukos DH
    Future Oncol; 2017 Dec; 13(30):2741-2744. PubMed ID: 29182377
    [No Abstract]   [Full Text] [Related]  

  • 4. Organoid models for translational pancreatic cancer research.
    Tiriac H; Plenker D; Baker LA; Tuveson DA
    Curr Opin Genet Dev; 2019 Feb; 54():7-11. PubMed ID: 30844513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of pancreatic cyst-cancer progression: standing on the shoulders of giants.
    Giri B; Sethi V; Dudeja V; Banerjee S; Livingstone A; Saluja A
    Curr Opin Gastroenterol; 2017 Sep; 33(5):404-410. PubMed ID: 28682795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology.
    Bazzichetto C; Luchini C; Conciatori F; Vaccaro V; Di Cello I; Mattiolo P; Falcone I; Ferretti G; Scarpa A; Cognetti F; Milella M
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.
    Qian Y; Gong Y; Fan Z; Luo G; Huang Q; Deng S; Cheng H; Jin K; Ni Q; Yu X; Liu C
    J Hematol Oncol; 2020 Oct; 13(1):130. PubMed ID: 33008426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomics of pancreatic ductal adenocarcinoma.
    Pilarsky C; Grutzmann R
    Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):381-5. PubMed ID: 25100122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine.
    Knudsen ES; O'Reilly EM; Brody JR; Witkiewicz AK
    Gastroenterology; 2016 Jan; 150(1):48-63. PubMed ID: 26385075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of Familial and Sporadic Pancreatic Cancer.
    Wood LD; Yurgelun MB; Goggins MG
    Gastroenterology; 2019 May; 156(7):2041-2055. PubMed ID: 30660730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic ductal adenocarcinoma treatment--the past, present, and future.
    Lavu H; Yeo CJ
    Semin Oncol; 2015 Feb; 42(1):4-7. PubMed ID: 25726047
    [No Abstract]   [Full Text] [Related]  

  • 12. Pancreatic cancer in 2017: Rebooting pancreatic cancer knowledge and treatment options.
    Semaan A; Maitra A
    Nat Rev Gastroenterol Hepatol; 2018 Feb; 15(2):76-78. PubMed ID: 29317774
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioinformatory-assisted analysis of next-generation sequencing data for precision medicine in pancreatic cancer.
    Malgerud L; Lindberg J; Wirta V; Gustafsson-Liljefors M; Karimi M; Moro CF; Stecker K; Picker A; Huelsewig C; Stein M; Bohnert R; Del Chiaro M; Haas SL; Heuchel RL; Permert J; Maeurer MJ; Brock S; Verbeke CS; Engstrand L; Jackson DB; Grönberg H; Löhr JM
    Mol Oncol; 2017 Oct; 11(10):1413-1429. PubMed ID: 28675654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can we move towards personalised pancreatic cancer therapy?
    Jamieson NB; Chang DK; Grimmond SM; Biankin AV
    Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):335-8. PubMed ID: 24702631
    [No Abstract]   [Full Text] [Related]  

  • 15. Building towards Precision Oncology for Pancreatic Cancer: Real-World Challenges and Opportunities.
    Wang Y; Lakoma A; Zogopoulos G
    Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32967105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Utility of Circulating Tumor DNA for Molecular Assessment and Precision Medicine in Pancreatic Cancer.
    Takai E; Totoki Y; Nakamura H; Kato M; Shibata T; Yachida S
    Adv Exp Med Biol; 2016; 924():13-17. PubMed ID: 27753011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse and precision therapies open new horizons for patients with advanced pancreatic ductal adenocarcinoma.
    Bai RL; Wang NY; Zhao LL; Zhang YF; Cui JW
    Hepatobiliary Pancreat Dis Int; 2022 Feb; 21(1):10-24. PubMed ID: 34538570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A step towards personalizing next line therapy for resected pancreatic and related cancer patients: A single institution's experience.
    Lowder CY; Dhir T; Goetz AB; Thomsett HL; Bender J; Tatarian T; Madhavan S; Petricoin EF; Blais E; Lavu H; Winter JM; Posey J; Brody JR; Pishvaian MJ; Yeo CJ
    Surg Oncol; 2020 Jun; 33():118-125. PubMed ID: 32561076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic cancer subtypes: a roadmap for precision medicine.
    Torres C; Grippo PJ
    Ann Med; 2018 Jun; 50(4):277-287. PubMed ID: 29537309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong?
    Connor AA; Gallinger S
    Expert Rev Gastroenterol Hepatol; 2017 Jul; 11(7):683-694. PubMed ID: 28460572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.